Company: SMNR
Filing Date: 2025-04-21
Form Type: S-4/A
Source: 0001193125-25-087342
Chunk: 295

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: S-4/A
Chunk 295
---
holders on or about , 2025 in connection with the vote on the Proposals. This proxy statement/prospectus provides you with the information you need to know to be able to vote or instruct your vote to be cast at the Meeting.

#### Date, Time and Place
The Meeting will be held at the offices of US Tiger Securities, Inc. located at 437 Madison Avenue, 27th Floor, New York, New York 10022 on , , 2025, or such other date, time and place to which such meeting may be adjourned or postponed, for the purposes set forth in the accompanying notice. Cayman Islands law requires there be a physical location for the Meeting.

#### Record Date; Who is Entitled to Vote
**Denali has fixed the close of business on , 2025, as the Record Date for determining those Denali shareholders entitled to notice of and to vote at the Meeting. As of the close of business on , 2025, there were 2,616,239 Denali Ordinary Shares issued and outstanding and entitled to vote, of which 43,739 are public shares (which includes 14,622 shares underlying the Public Units), 2,062,500 are Denali Class B Ordinary Shares held by the Initial Shareholders and Scilex and 510,000 are Denali Class A Ordinary Shares underlying the Denali Private Placement Units held by the Sponsor. Each holder of Denali Ordinary Shares is entitled to one vote per share on each Proposal; provided that holders of Denali Class B ordinary shares will have ten votes per share solely with respect to the Domestication Proposal. If your shares are held in “street name,” you should contact your broker, bank or other nominee to ensure that shares held beneficially by you are voted in accordance with your instructions.

In connection with the IPO, we entered into certain letter agreements pursuant to which the Initial Shareholders agreed to vote any Denali Ordinary Shares owned by them in favor of our initial business combination. The Initial Shareholders also entered into a certain support agreement with Semnur, pursuant to which they agreed to, among other things, vote in favor of the Business Combination Proposal and the other proposals. As of the date of this proxy statement/prospectus, the Initial Shareholders hold approximately 55.5% of the outstanding Denali Ordinary Shares.

Quorum and Required Vote for Shareholder Proposals

A quorum of Denali’s shareholders is necessary to hold a valid meeting. The presence, in person or